Patent ID: 6541464
Filing Date: 2003-04-01
Classification: A61P,C07J

Abstract:
A method of lowering serum cholesterol levels in humans comprising administering to humans an amount of a compound selected from the group consisting of a compound of the formula wherein n is 2 or 3, R1 and R2 are individually hydrogen or alkyl of 1 to 4 carbon atoms or together with the nitrogen form an unsaturated or saturated, unsubstituted or substituted, aromatic or non-aromatic mono- or polycyclic heterocycle of 5 to 15 ring members and optionally containing 1 to 3 additional heteroatoms selected from the group consisting of oxygen, sulfur and nitrogen, X is â€”OH or acyloxy and Y is unsubstituted or substituted alkyl of 1 to 4 carbon atoms and its non-toxic, pharmaceutically acceptable acid addition salts.